Who is sponsoring NCT05284279?

NCT05284279 is sponsored by Hospices Civils de Lyon.

What condition does NCT05284279 study?

NCT05284279 studies Early Childhood Caries (ECC).

Is NCT05284279 still recruiting?

NCT05284279 is currently status unknown. Last updated 17 March 2022.

Last reviewed 2022-03-17 · How we verify

NCT05284279: CariStigma

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Childhood Caries and Health Professionals' Perception: a Qualitative Research Protocol to Assess Oral Health Stigma

Status unknown Last updated 17 March 2022

What this trial tests

trial testing Exploring health professionals' perceptions of patients with ECC using semi-structured interviews in Early Childhood Caries (ECC) in 30 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
1 December 2022

1 September 2023

Quick facts

Lead sponsor	Hospices Civils de Lyon
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 June 2022
Primary completion	1 December 2022
Estimated completion	1 September 2023
Sites	1 location across France

Drugs / interventions tested

Exploring health professionals' perceptions of patients with ECC using semi-structured interviews

Conditions studied

Early Childhood Caries (ECC) — all drugs for Early Childhood Caries (ECC) →

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

Eligibility, any sex, with Early Childhood Caries (ECC). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dental caries is the most common non-communicable disease in childhood. Disease management of caries rests on surgical treatment as well as various preventive strategies such as fluoridation, sealants, personal counselling... With other non-communicable diseases (obesity, overweight…), it has been demonstrated that health professionals' negative perceptions of their patients could affect disease management quality. Concerning dental caries, some data might suggest that discriminating believes and behaviours toward children with dental caries and their families exist in the medical setting. However, oral health related stigma remains an unexplored issue. This study would be the first to our knowledge to specifically address the question of stigmatisation and discrimination of patients with dental caries. The present project is to conduct an exploratory study focusing on perceptions and attitudes of health professionals toward children with early childhood caries and their parents. The questions the study aims to answer are: (i) What are health professionals 'perceptions of children with ECC and their family? And (ii) according to health professionals, do these perceptions influence the quality of their care? We hypothesize that some practitioners have negative opinions on children with ECC and their parents, affecting the quality of their care, especially concerning oral health prevention. Method: Individual semi-structured interviews will be conducted among dentists (general or pediatric), general practitioners and paediatricians.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

What are health professionals' perceptions and attitudes regarding children with early childhood caries and their families? A qualitative research protocol to assess oral health stigma in the medical setting.
Lienhart G, Thivichon-Prince B, Farge P, Schott-Pethelaz AM, et al · · 2022 · cited 2× · PMID 36455999 · DOI 10.1136/bmjopen-2022-066680
Are Children with Early Childhood Caries and Their Families Stigmatized? Perceptions and Practices of Dental Professionals: A Qualitative Study
Lienhart G, Verroul M, Farge P, Schott-pethelaz A, et al · · 2025 · DOI 10.21203/rs.3.rs-7648443/v1

Verify or expand the search:

Other recruiting trials for Early Childhood Caries (ECC)

Currently open trials in the same condition.

NCT07455604 — Preventing Early Childhood Caries With a Silver Diamine Fluoride Gel · Phase 2 · active not recruiting

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05284279 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
Last refreshed: 17 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05284279.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing